Last Updated : 06/20/2022
Yoshihiro Oka is in Suita, Japan. Oka is rated as an Elite expert by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 5 other conditions, according to our data. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Wilms Tumor, Familial Wilms Tumor 2, and Adult T-Cell Leukemia.
Shigeo Koido is in Kashiwa, Japan. Koido is rated as an Elite expert by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 7 other conditions, according to our data. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Wilms Tumor, Pancreatic Cancer, and Pancreatic Ductal Adenocarcinoma.
Sumiyuki Nishida is in Osaka, Japan. Nishida is rated as an Elite expert by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. They are also highly rated in 3 other conditions, according to our data. Their top areas of expertise are WT1-Related Wilms Tumor Syndromes, Wilms Tumor, Familial Wilms Tumor 2, and Adult T-Cell Leukemia.
Yusuke Oji is in Osaka, Japan. Oji is rated as an Elite expert by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 7 other conditions, according to our data. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Wilms Tumor, Familial Wilms Tumor 2, and Ganglioneuroma.
Jun Nakata is in Osaka, Japan. Nakata is rated as an Elite expert by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 3 other conditions, according to our data. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Wilms Tumor, Familial Wilms Tumor 2, and Leukemia.
Sumanta Pal is an Oncologist in Newport Beach, California. Dr. Pal has been practicing medicine for over 19 years and is rated as a Distinguished doctor by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 23 other conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma RCC, Chromophobe Renal Cell Carcinoma, Urothelial Cancer, and Prostate Cancer. He is licensed to treat patients in California.
Anil Veluvolu is a Hematologist Oncology specialist and a Hematologist in Shreveport, Louisiana. Dr. Veluvolu has been practicing medicine for over 23 years and is rated as a Distinguished doctor by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 112 other conditions, according to our data. His top areas of expertise are Gastric Lymphoma, Familial Wilms Tumor 2, Wilms Tumor, and WT1-Related Wilms Tumor Syndromes. He is licensed to treat patients in Louisiana. Dr. Veluvolu is currently accepting new patients.
Britt Bolemon is a Hematologist Oncology specialist and an Oncologist in Greenville, South Carolina. Dr. Bolemon has been practicing medicine for over 16 years and is rated as a Distinguished doctor by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 86 other conditions, according to our data. His top areas of expertise are Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, Familial Wilms Tumor 2, and Wilms Tumor. He is licensed to treat patients in North Carolina and South Carolina. Dr. Bolemon is currently accepting new patients.
Thomas Guzzo is an Urologist in Philadelphia, Pennsylvania. Dr. Guzzo has been practicing medicine for over 20 years and is rated as a Distinguished doctor by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 29 other conditions, according to our data. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Renal Cell Carcinoma RCC, and Chromophobe Renal Cell Carcinoma. He is licensed to treat patients in Pennsylvania. Dr. Guzzo is currently accepting new patients.
Rana Mckay is a Hematologist Oncology doctor in La Jolla, California. Dr. Mckay has been practicing medicine for over 14 years and is rated as a Distinguished doctor by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. She is also highly rated in 16 other conditions, according to our data. Her top areas of expertise are Prostate Cancer, Renal Cell Carcinoma RCC, Chromophobe Renal Cell Carcinoma, and Familial Prostate Cancer. She is licensed to treat patients in Massachusetts. Dr. Mckay is currently accepting new patients.
Theodore Gourdin is a Hematologist and an Oncologist in Charleston, South Carolina. Dr. Gourdin is rated as a Distinguished doctor by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 23 other conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma RCC, Chromophobe Renal Cell Carcinoma, Wilms Tumor, and WT1-Related Wilms Tumor Syndromes. He is licensed to treat patients in South Carolina. Dr. Gourdin is currently accepting new patients.
Joseph Clark is a Hematologist Oncology doctor in Maywood, Illinois. Dr. Clark has been practicing medicine for over 33 years and is rated as a Distinguished doctor by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 32 other conditions, according to our data. His top areas of expertise are Wilms Tumor, WT1-Related Wilms Tumor Syndromes, Familial Wilms Tumor 2, and Chromophobe Renal Cell Carcinoma. He is licensed to treat patients in Illinois. Dr. Clark is currently accepting new patients.
Daniel Geynisman is an Oncologist and a Transplant Surgeon in Philadelphia, Pennsylvania. Dr. Geynisman has been practicing medicine for over 16 years and is rated as a Distinguished doctor by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 13 other conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma RCC, Chromophobe Renal Cell Carcinoma, Urothelial Cancer, and Bladder Cancer. He is licensed to treat patients in Pennsylvania. Dr. Geynisman is currently accepting new patients.
Kevin Becker is a Hematologist Oncology doctor in Brooklyn, New York. Dr. Becker has been practicing medicine for over 18 years and is rated as a Distinguished doctor by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 39 other conditions, according to our data. His top areas of expertise are Leiomyosarcoma, Familial Wilms Tumor 2, Wilms Tumor, and WT1-Related Wilms Tumor Syndromes. He is licensed to treat patients in New York. Dr. Becker is currently accepting new patients.
Ronald Kaufman is an Urologist in Albany, New York. Dr. Kaufman has been practicing medicine for over 39 years and is rated as a Distinguished doctor by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 24 other conditions, according to our data. His top areas of expertise are Aquablation, Enlarged Prostate, Ureterocele, and Renal Cell Carcinoma RCC. He is licensed to treat patients in New York. Dr. Kaufman is currently accepting new patients.
Inoel Rivera-Ramirez is an Urologist in Orlando, Florida. Dr. Rivera-Ramirez has been practicing medicine for over 32 years and is rated as a Distinguished doctor by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 24 other conditions, according to our data. His top areas of expertise are Obstructive Uropathy, Hydronephrosis, Bilateral Hydronephrosis, and Prostate Cancer. He is licensed to treat patients in Florida. Dr. Rivera-Ramirez is currently accepting new patients.
Benedito Carneiro-Filho is an Oncologist and a Hematologist Oncology doctor in Providence, Rhode Island. Dr. Carneiro-Filho has been practicing medicine for over 22 years and is rated as a Distinguished doctor by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 20 other conditions, according to our data. His top areas of expertise are Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Renal Cell Carcinoma RCC, and Clear Cell Sarcoma. He is licensed to treat patients in Rhode Island and Illinois. Dr. Carneiro-Filho is currently accepting new patients.
Gopal Gupta is an Urologist in Melrose Park, Illinois. Dr. Gupta has been practicing medicine for over 20 years and is rated as a Distinguished doctor by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 18 other conditions, according to our data. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma RCC, Chromophobe Renal Cell Carcinoma, and Bladder Cancer. He is licensed to treat patients in Illinois. Dr. Gupta is currently accepting new patients.
Daniel George is a Hematologist Oncology specialist and an Urologist in Durham, North Carolina. Dr. George is rated as a Distinguished doctor by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 15 other conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma RCC, Prostate Cancer, Chromophobe Renal Cell Carcinoma, and Familial Prostate Cancer. He is licensed to treat patients in North Carolina. Dr. George is currently accepting new patients.
Steven Raman is a Radiologist and an Interventional Radiologist in Los Angeles, California. Dr. Raman has been practicing medicine for over 29 years and is rated as a Distinguished doctor by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 7 other conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma RCC, WT1-Related Wilms Tumor Syndromes, Fibrolamellar Carcinoma, and Prostate Cancer. He is licensed to treat patients in California. Dr. Raman is currently accepting new patients.
Last Updated : 06/20/2022
MediFind is the industry authority on identifying the leading medical experts and latest research in order to help patients facing complex health challenges, including WT1-Related Wilms Tumor Syndromes, make better health decisions. Leveraging our expertise in natural language processing and machine learning across thousands of diseases, we uncover physicians who are leading authorities on WT1-Related Wilms Tumor Syndromes. MediFind identifies these experts using proprietary world-class models that assess over 2.5 million global doctors based on a range of variables, including research leadership, patient volume, peer standing, and connectedness to other experts. Learn more about our methodology by exploring how MediFind works.